The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.
The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.
复制标题
种族和刑事司法参与对精神分裂症患者获得非典型抗精神病药物的影响。
DOI：
10.1007/s11020-005-3783-z
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
Elbogen,EricB
中科院分区：
文献类型：
--
作者：
VanDorn,RichardA;Swanson,JeffreyW;Swartz,MarvinS;Elbogen,EricB
这项研究考察了种族和逮捕史对社区精神分裂症患者服用非典型抗精神病药物处方的可能性以及维持非典型抗精神病药物处方90天或更长时间的影响。参与者是224名在北卡罗来纳州公共部门精神卫生系统接受服务的精神分裂症谱系障碍成年人。本报告使用的数据来自一项观察性研究中随访的较大参与者组的子样本，包括接受非典型或常规抗精神病药物治疗90天或更长时间的个体。本文分析的目的是调查不同人口统计学和其他特征的非典型抗精神病药的可能性差异。Logistic回归分析表明，非裔美国人患者接受非典型抗精神病药物的可能性明显低于他们的白色同行，即使在控制了关键的临床和人口统计学变量。然而，有逮捕史的白色患者接受非典型抗精神病药物的可能性并不比黑人患者高;也就是说，少数民族的种族地位和犯罪参与都限制了患者获得新型药物。平等获得精神卫生服务的影响，在这种情况下，有效的精神药理学治疗，进行了讨论。
This study examined the impact of race and arrest history on the likelihood of being prescribed, and maintaining an atypical antipsychotic prescription for 90 or more days among patients with schizophrenia in the community. Participants were 224 adults with schizophrenia-spectrum disorders receiving services in public-sector mental health systems in North Carolina. The data used for this report were from a subsample of a larger group of participants being followed in an observational study and consisted of individuals who were prescribed either an atypical or conventional antipsychotic medication for 90 or more days. The purpose of the analyses presented here was to investigate differences in the likelihood of being prescribed an atypical antipsychotic by demographic and other characteristics. Logistic regression analysis indicated that African American patients were significantly less likely to receive atypical antipsychotics than their white counterparts, even when controlling for key clinical and demographic variables. However, white patients with a history of arrest were no more likely than black patients to receive atypical antipsychotics; that is, minority racial status and criminal involvement each functioned to limit patients’ access to the novel medications. Implications for equal access to mental health services, in this case, effective psychopharmacologic treatment, are discussed.